Ono Pharma Files Approval Application in Japan for Ripretinib in Advanced Gastrointestinal Stromal Tumor
Ono Pharma Files for Approval of Ripretinib (DCC-2618) to Treat Advanced Gastrointestinal Stromal Tumors in Japan Ono Pharmaceutical Co., Ltd. has announced the submission of a regulatory application in Japan…
Neurocrine Biosciences Unveils First Expert Consensus Guidelines for Tardive Dyskinesia in Long-Term Care Settings
Neurocrine Biosciences Unveils First Expert Consensus Guidelines for Managing Tardive Dyskinesia in Long-Term Care Settings Neurocrine Biosciences, Inc. today announced the presentation of the first expert consensus recommendations focused on screening,…
Allergan Aesthetics Introduces Next-Generation JUVÉDERM Hyaluronic Acid Injectables at AMWC Monaco
Allergan Aesthetics Introduces Next-Generation Hyaluronic Acid Injectables with JUVÉDERM at AMWC Monaco Allergan Aesthetics, an AbbVie company, a global leader in medical aesthetics treatments and manufacturers of the market-leading JUVÉDERM® Collection…
Novo Nordisk Secures U.S. Approval for Awiqli, the First Once-Weekly Basal Insulin for Adults with Type 2 Diabetes
Novo Nordisk Secures U.S. Approval for Awiqli, the First Once-Weekly Basal Insulin for Adults with Type 2 Diabetes Novo Nordisk today announced that the US Food and Drug Administration (FDA)…
Abcuro Reports Phase 2/3 MUSCLE Study Results of Ulviprubart in Inclusion Body Myositis at GCOM 2026
Abcuro Highlights Phase 2/3 MUSCLE Study Results of Ulviprubart in Inclusion Body Myositis at GCOM 2026 Abcuro, Inc. has announced new clinical data from its Phase 2/3 MUSCLE study evaluating…
Drug Farm Secures U.S. FDA Orphan Drug Designation for DF-003 to Treat ROSAH Syndrome
Drug Farm Secures U.S. FDA Orphan Drug Designation for DF-003 in Treating ROSAH Syndrome Drug Farm has announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug…
Nordic Cold Chain Solutions Unveils GLP-1 and Small-Format Packaging Innovation Lab
Nordic Cold Chain Solutions Unveils Innovation Lab Focused on GLP-1 and Small-Format Packaging Solutions Nordic Cold Chain Solutions has announced the launch of its GLP-1 & Small-Format Packaging Innovation Lab,…
Invivoscribe® Strengthens IVDR Portfolio with Certification of IdentiClone® Dx IGH Assay
Invivoscribe Expands IVDR Portfolio with Certification of IdentiClone Dx IGH Assay Invivoscribe, a globally recognized leader in precision diagnostics and measurable residual disease (MRD) testing, has announced a major regulatory…
Aledade Partners Surpass Major Health Systems in Hypertension Control, New Case Study Finds
Aledade Partners Demonstrate Superior Hypertension Control, Surpassing Large Health Systems in New Case Study Aledade, a physician-led organization recognized as a national leader in advancing value-based care, has released the…
Alpha Cognition Reports Fiscal 2025 Financial Results and Operational Update
Alpha Cognition Inc. Announces Fiscal 2025 Financial Results and Operational Progress Update Alpha Cognition Inc., a clinical-stage biopharmaceutical company focused on developing innovative treatments for neurodegenerative disorders, has reported its…
Agenus to Host March 2026 Webcast on Advancing BOT + BAL Immunotherapy Across Tumors
Agenus to Host March 2026 Stakeholder Webcast Highlighting Progress of BOT + BAL Immunotherapy and Expanding Patient Access Across Multiple Tumor Types Agenus Inc., a biotechnology company focused on advancing…
Biocytogen Announces U.S. Food and Drug Administration IND Clearance for NEOK Bio’s NEOK002 Targeting Solid Tumors
Biocytogen Announces U.S. Food and Drug Administration IND Clearance for Partner NEOK Bio’s NEOK002 in Solid Tumor Indications Biocytogen Pharmaceuticals (Beijing) Co., Ltd. has announced a significant regulatory milestone achieved…